Caltech Biologists Receive High-Risk, High-Reward Grants from the NIH

Caltech faculty members Mitchell Guttman and Markus Meister (PhD ‘87) have been selected to receive “high-risk, high-reward” grants from the National Institutes of Health (NIH) for cutting-edge work in biomedical science and neuroscience. Guttman’s funded work could enable new methods to produce antibodies for any possible protein—a development with implications for both basic laboratory tests and clinical care. Meanwhile, Meister’s research aims to explain arguably the core question of neuroscience: how the brain organizes human behavior.